These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies. Bello L; Campadello P; Barp A; Fanin M; Semplicini C; Sorarù G; Caumo L; Calore C; Angelini C; Pegoraro E Sci Rep; 2016 Sep; 6():32439. PubMed ID: 27582364 [TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy]. den Dunnen JT; de Visser M; Bakker E Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623 [TBL] [Abstract][Full Text] [Related]
24. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup. Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761 [TBL] [Abstract][Full Text] [Related]
25. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy. Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738 [TBL] [Abstract][Full Text] [Related]
27. Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy. Shim JY; Kim TS Yonsei Med J; 2003 Feb; 44(1):15-23. PubMed ID: 12619170 [TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Yoshida K; Ikeda S; Nakamura A; Kagoshima M; Takeda S; Shoji S; Yanagisawa N Muscle Nerve; 1993 Nov; 16(11):1161-6. PubMed ID: 8413368 [TBL] [Abstract][Full Text] [Related]
29. Becker muscular dystrophy severity is linked to the structure of dystrophin. Nicolas A; Raguénès-Nicol C; Ben Yaou R; Ameziane-Le Hir S; Chéron A; Vié V; Claustres M; Leturcq F; Delalande O; Hubert JF; Tuffery-Giraud S; Giudice E; Le Rumeur E; Hum Mol Genet; 2015 Mar; 24(5):1267-79. PubMed ID: 25348330 [TBL] [Abstract][Full Text] [Related]
30. [Clinical features of patients with Becker muscular dystrophy and deletions of the rod domain of dystrophin gene]. Wang Y; Zhu Y; Yang J; Li Y; Sun J; Zhan Y; Zhang C Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):14-17. PubMed ID: 29419852 [TBL] [Abstract][Full Text] [Related]
31. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript. Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544 [TBL] [Abstract][Full Text] [Related]
32. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Viggiano E; Ergoli M; Picillo E; Politano L Hum Genet; 2016 Jul; 135(7):685-98. PubMed ID: 27098336 [TBL] [Abstract][Full Text] [Related]
33. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Kaspar RW; Allen HD; Ray WC; Alvarez CE; Kissel JT; Pestronk A; Weiss RB; Flanigan KM; Mendell JR; Montanaro F Circ Cardiovasc Genet; 2009 Dec; 2(6):544-51. PubMed ID: 20031633 [TBL] [Abstract][Full Text] [Related]
34. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404 [TBL] [Abstract][Full Text] [Related]
35. Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies. Lim KRQ; Sheri N; Nguyen Q; Yokota T Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650403 [TBL] [Abstract][Full Text] [Related]
36. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy. Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626 [TBL] [Abstract][Full Text] [Related]
37. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies. Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801 [TBL] [Abstract][Full Text] [Related]
38. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context. Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249 [TBL] [Abstract][Full Text] [Related]
39. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs. Maruyama R; Aoki Y; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554 [TBL] [Abstract][Full Text] [Related]
40. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]